119 related articles for article (PubMed ID: 37715374)
1. Circ-PRMT5 stimulates the proliferative ability in Wilms' tumor through the miR-7-5p/KLF4 axis.
Zhang J; Quan Y; Su X; Qiu B; Dong Q
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):232-236. PubMed ID: 37715374
[TBL] [Abstract][Full Text] [Related]
2. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-27a-5p Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis of Wilms' Tumor Cell by Targeting PBOV1.
Guo ZT; Yu Q; Miao C; Ge W; Li P
Mol Cell Biol; 2022 Aug; 42(8):e0039721. PubMed ID: 35862727
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis.
Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M
J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592
[TBL] [Abstract][Full Text] [Related]
5. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
Ding Z; Guo L; Deng Z; Li P
Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
[TBL] [Abstract][Full Text] [Related]
6. Circ-PRMT5 promotes breast cancer by the miR-509-3p/TCF7L2 axis activating the PI3K/AKT pathway.
Wu D; Jia H; Zhang Z; Li S
J Gene Med; 2021 Feb; 23(2):e3300. PubMed ID: 33277756
[TBL] [Abstract][Full Text] [Related]
7. Aloin decelerates the progression of hepatocellular carcinoma through circ_0011385/miR-149-5p/WT1 axis.
Fu D; Ji Q; Wang C; Yu L; Yu R
Cell Cycle; 2021 Dec; 20(23):2476-2493. PubMed ID: 34720052
[TBL] [Abstract][Full Text] [Related]
8. Effect of miR-590-3p/DKK1 Axis on the Progression of Wilms' Tumour.
Wang H; Zhang Y
Arch Esp Urol; 2024 Mar; 77(2):135-141. PubMed ID: 38583005
[TBL] [Abstract][Full Text] [Related]
9. Circular non-coding RNA circ_0072088 serves as a ceRNA, targeting the miR-1225-5p/WT1 axis to regulate non-small cell lung cancer cell malignant behavior.
Zhu X; Wan J; You X; Yang W; Zhao L
Thorac Cancer; 2023 Jul; 14(20):1969-1979. PubMed ID: 37220935
[TBL] [Abstract][Full Text] [Related]
10. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
[TBL] [Abstract][Full Text] [Related]
11. Circ_0005875 sponges miR-502-5p to promote renal cell carcinoma progression through upregulating E26 transformation specific-1.
Luo S; Deng F; Yao N; Zheng F
Anticancer Drugs; 2022 Jan; 33(1):e286-e298. PubMed ID: 34407050
[TBL] [Abstract][Full Text] [Related]
12. Circ-PRMT5 stimulates migration in esophageal cancer by binding miR-203.
Zhang LW; Wang B; Yang JX; Yang H
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9965-9972. PubMed ID: 33090401
[TBL] [Abstract][Full Text] [Related]
13. EMX2OS Delays Wilms'Tumor Progression via Targeting miR-654-3p.
Chen ZH; Cui MY; Zhang HM
Ann Clin Lab Sci; 2022 Jan; 52(1):12-20. PubMed ID: 35181613
[TBL] [Abstract][Full Text] [Related]
14. Circ_0068631 sponges miR-139-5p to promote the growth and metastasis of cutaneous squamous cell carcinoma by upregulating HOXB7.
Ji J; Xiong C; Peng J; Zhang N; Zhang Y; Yang H; Zhu W
Skin Res Technol; 2023 Feb; 29(2):e13248. PubMed ID: 36823512
[TBL] [Abstract][Full Text] [Related]
15. LINC00858 facilitates the malignant development of Wilms' tumor by targeting miR-653-5p.
Zhou D; Wang J; Xu S; Li Z; Kou D
Minerva Med; 2020 Jun; ():. PubMed ID: 32538587
[TBL] [Abstract][Full Text] [Related]
16. Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR-136-5p/YWHAZ axis.
Kong Z; Han Q; Zhu B; Wan L; Feng E
Thorac Cancer; 2023 Jul; 14(19):1831-1842. PubMed ID: 37192740
[TBL] [Abstract][Full Text] [Related]
17. Propofol Suppresses Glioma Tumorigenesis by Regulating circ_0047688/miR-516b-5p/IFI30 Axis.
Li Y; Liu Y; Zhang J; Li J; Shu Y
Biochem Genet; 2023 Feb; 61(1):151-169. PubMed ID: 35763173
[TBL] [Abstract][Full Text] [Related]
18. Circ_0000069 contributes to the growth, metastasis and glutamine metabolism in renal cell carcinoma (RCC) via regulating miR-125a-5p-dependent SLC1A5 expression.
Yang L; Wang L; Wu J; Wang Y
Transpl Immunol; 2023 Apr; 77():101764. PubMed ID: 36462557
[TBL] [Abstract][Full Text] [Related]
19. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p.
Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F
Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer.
Pang J; Ye L; Zhao D; Zhao D; Chen Q
Cell Biol Int; 2020 Dec; 44(12):2416-2426. PubMed ID: 32808744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
